ロード中...
Chemical Incorporation of Chain-Terminating Nucleoside Analogs as 3′-Blocking DNA Damage and Their Removal by Human ERCC1-XPF Endonuclease
Nucleoside/nucleotide analogs that lack the 3′-hydroxy group are widely utilized for HIV therapy. These chain-terminating nucleoside analogs (CTNAs) block DNA synthesis after their incorporation into growing DNA, leading to the antiviral effects. However, they are also considered to be DNA damaging...
保存先:
| 出版年: | Molecules |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6273010/ https://ncbi.nlm.nih.gov/pubmed/27294910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules21060766 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|